Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Atherosclerosis

• Publication date

  1991-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0021-9150(91)90016-VPMID 1906713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells.

  1990cited by this paper
• Purification of an apolipoprotein A binding protein from mouse adipose cells.

  1990cited by this paper
• In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins.

  1989cited by this paper
• Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein.

  1988cited by this paper
• HDL receptor and reverse cholesterol transport in adipose cells.

  1988cited by this paper
• Differential effect of ultracentrifugation on apolipoprotein A-I-containing lipoprotein subpopulations.

  1988cited by this paper
• Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles.

  1987cited by this paper
• Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay.

  1987cited by this paper
• Apolipoprotein A-I containing lipoproteins in coronary artery disease.

  1987cited by this paper
• Relationship in adipose cells between the presence of receptor sites for high density lipoproteins and the promotion of reverse cholesterol transport.

  1987cited by this paper
• Primary structure of apolipoprotein A-II from inbred mouse strain BALB/c.

  1987cited by this paper
• Effect of apolipoprotein E-free high density lipoproteins on cholesterol metabolism in cultured pig hepatocytes.

  1987cited by this paper
• Characterization of high-density lipoprotein binding and cholesterol efflux in cultured mouse adipose cells.

  1986cited by this paper
• Characterization of apolipoprotein A-containing lipoproteins.

  1986cited by this paper
• Binding of lipoproteins and regulation of cholesterol synthesis in cultured mouse adipose cells.

  1985cited by this paper
• Distribution of apolipoprotein A-IV in human plasma.

  1985cited by this paper
• Immunoaffinity isolation of apolipoprotein E-containing lipoproteins.

  1985cited by this paper
• Adipose tissue and cholesterol metabolism.

  1984cited by this paper
• The lipid transport system in the mouse, Mus musculus: isolation and characterization of apolipoproteins B, A-I, A-II, and C-III.

  1984cited by this paper
• Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy.

  1983cited by this paper
• Incorporation of defined cholesteryl esters into lipoproteins using cholesteryl ester-rich microemulsions.

  1982cited by this paper
• The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity.

  1981cited by this paper
• Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.

  1980cited by this paper
• Establishment of preadipocyte clonal line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones.

  1978cited by this paper
• A new enzymatic method for determination of serum choline-containing phospholipids.

  1977cited by this paper
• The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

  1972cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• APOA2 increases cholesterol efflux capacity to plasma HDL by displacing the C-terminus of resident APOA1

  2024cites this paper
• Apolipoprotein‐Containing Lipoprotein Subclasses and Subclinical Atherosclerosis in Systemic Lupus Erythematosus

  2015cites this paper
• Investigation of lipodystrophy syndrome in a multicentre prospective cohort of HIV-infected children and adolescents living in Europe

  2013cites this paper
• Unfavorable apoAI-containing lipoproteins profile in Tunisian obese women group

  2012influential citation
• Factors impacting on the microbiological quality and safety of processed hake

  2010cites this paper
• Cholesterol efflux in adipose tissue

  2007cites this paper
• Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat?

  2005cites this paper
• Nutritional Intervention Study with Argan Oil in Man: Effects on Lipids and Apolipoproteins

  2005cites this paper
• The concept of apolipoprotein-defined lipoprotein families and its clinical significance

  2003cites this paper
• Scavenger receptor BI (SR-BI) mediates a higher selective cholesteryl ester uptake from LpA-I compared with LpA-I:A-II lipoprotein particles.

  2003cites this paper
• On the atherogenicity of triglyceride-rich lipoproteins and novel markers for the assessment of their atherogenic potentials

  2002cites this paper
• Apolipoprotein A-II, HDL metabolism and atherosclerosis.

  2002cites this paper
• A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene cluster.

  2002cites this paper
• HDL: a molecular view of the "classic" antiatherogenic lipoprotein

  2002cites this paper
• Dynamics of reverse cholesterol transport: protection against atherosclerosis.

  2002cites this paper
• The Pancreas and Lipoprotein Metabolism

  2001cites this paper
• Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): importance of PLTP in prebeta-HDL generation.

  2001cites this paper
• Beverage Alcohol Consumption as a Negative Risk Factor for Coronary Heart Disease: Biochemical Mechanisms

  2001cites this paper
• Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles.

  2000cites this paper
• Effects of alcohol on lipids and lipoprotein metabolism.

  2000cites this paper
• [Lipoprotein particles LpA-I, LpA-I: A-II and LpB in coronary artery disease].

  2000cites this paper
• Binding of High Density Lipoprotein (HDL) and Discoidal Reconstituted HDL to the HDL Receptor Scavenger Receptor Class B Type I*

  2000cites this paper
• The Effects of Insulin on Serum Levels of Apo A-I Containing Lipoprotein Particles in Syndrome X Patients With Coronary Heart Disease

  1999cites this paper
• Brain lipoprotein metabolism and its relation to neurodegenerative disease.

  1999cites this paper
• ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.

  1999cites this paper
• Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.

  1999cites this paper
• Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients.

  1999cites this paper
• Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome. Importance of the hdl-phospholipids/free cholesterol ratio and of the hdl size distribution.

  1999cites this paper
• Cell cholesterol efflux: integration of old and new observations provides new insights.

  1999cites this paper
• High-density lipoprotein subclasses and apolipoprotein A-I.

  1999cites this paper
• Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice.

  1998cites this paper
• Quantification of apolipoprotein AI-containing lipoprotein particles in non-insulin-dependent diabetes mellitus.

  1998cites this paper
• Selective uptake of cholesteryl esters from high-density lipoprotein-derived LpA-I and LpA-I:A-II particles by hepatic cells in culture.

  1998cites this paper
• Binding of phospholipid transfer protein (PLTP) to apolipoproteins A-I and A-II: location of a PLTP binding domain in the amino terminal region of apoA-I.

  1998cites this paper
• Isolation of subpopulations of high density lipoproteins: three particle species containing apoE and two species devoid of apoE that have affinity for heparin.

  1997cites this paper
• Composition and structural and functional properties of discoidal and spherical phospholipid-apoE3 complexes.

  1997cites this paper
• Lipoproteins and cellular cholesterol homeostasis.

  1997cites this paper
• The Carboxyl-terminal Hydrophobic Residues of Apolipoprotein A-I Affect Its Rate of Phospholipid Binding and Its Association with High Density Lipoprotein*

  1997cites this paper
• Transformation of high density lipoprotein 2 particles by hepatic lipase and phospholipid transfer protein.

  1997cites this paper
• Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII).

  1997cites this paper
• Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake.

  1997cites this paper
• Abnormalities of serum apo A1 containing lipoprotein particles in patients with primary biliary cirrhosis.

  1997cites this paper
• Clathrin-mediated endocytosis of high density lipoprotein3 in human intestinal Caco-2 cells. A post-embedding immunocytochemical study.

  1997cites this paper
• Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.

  1997cites this paper
• The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux.

  1996cites this paper
• Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate.

  1996cites this paper
• Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins.

  1996cites this paper
• Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein.

  1996cites this paper
• Structural relationships between nascent apoA-I-containing particles that are extracellularly assembled in cell culture.

  1996cites this paper
• Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages.

  1996cites this paper
• Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.

  1996cites this paper
• Apolipoprotein AIV of human interstitial fluid is associated with apolipoprotein AI-containing but not with AII-containing particles

  1996cites this paper
• Reverse cholesterol transport: its contribution to cholesterol catabolism in normal and disease states.

  1996cites this paper
• Apolipoprotein-AI-containing particles and atherosclerosis.

  1996cites this paper
• Decreased Interstitial Apolipoprotein A-I Levels in IDDM Patients with Diabetic Nephropathy

  1995cites this paper
• Cholesterol transfer from low density lipoproteins to reconstituted high density lipoproteins is determined by the properties and concentrations of both particles.

  1995cites this paper
• Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages.

  1995cites this paper
• Molecular physiology of reverse cholesterol transport.

  1995cites this paper
• Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma.

  1995cites this paper
• Effect of gemfibrozil on the regulation of HDL subfractions in hypertriglyceridaemic patients

  1995cites this paper
• Monensin and Brefeldin A Inhibit High Density Lipoprotein- mediated Cholesterol Efflux from Cholesterol-enriched Cells

  1995cites this paper
• Effects of interactions of apolipoprotein A-II with apolipoproteins A-I or A-IV on [3H]cholesterol efflux and uptake in cell culture.

  1995cites this paper
• HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus.

  1995cites this paper
• ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.

  1995cites this paper
• Characterization of high-density apolipoprotein particles A-I and A-I:A-II isolated from humans with cholesteryl ester transfer protein deficiency.

  1995cites this paper
• Cholesterol efflux from human monocyte-derived macrophages in the presence of LpA-I:A-II.

  1995cites this paper
• Modulation of Cholesterol Efflux from Fu5AH Hepatoma Cells by the Apolipoprotein Content of High Density Lipoprotein Particles.

  1995cites this paper
• Apo A-I Containing Particles and Atherosclerosis

  1995cites this paper
• Drug control of reverse cholesterol transport.

  1994cites this paper
• High—Monounsaturated Fat Diet for Diabetic Patients: Is it time to change the current dietary recommendations?

  1994cites this paper
• In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport.

  1994cites this paper
• Transfer of cholesterol from Ob1771 cells or LDL to reconstituted, defined high density lipoproteins.

  1994cites this paper
• The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects.

  1994cites this paper
• Lipoprotein receptors.

  1994cites this paper
• Physical Activity and Lipoprotein Lipid Disorders

  1994cites this paper
• Extravascular circulation of lipoproteins: their role in reverse transport of cholesterol.

  1994cites this paper
• A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer.

  1994cites this paper
• HDL3-mediated cholesterol efflux from cultured enterocytes: The role of apoproteins A-I and A-II

  1994cites this paper
• Native-like structure and self-association behavior of apolipoprotein A-I in a water/n-propanol solution.

  1994cites this paper
• HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age.

  1993cites this paper
• Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia.

  1993cites this paper
• Regulation of Apolipoprotein A-I–Containing Lipoproteins in IDDM

  1993cites this paper
• Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.

  1993cites this paper
• Functional Properties of Discoidal Apoprotein/Phospholipid Complexes: Cholesterol Efflux from Macrophages and Conversion by Lecithin-Cholesterol Acyl Transferase

  1993cites this paper
• Hormonal Control of Genes Involved in Lipoprotein Metabolism in the Rat

  1993cites this paper
• Heterogeneity of High Density Lipoprotein Particles

  1993cites this paper
• Tangier disease: isolation and characterization of LpA-I, LpA-II, LpA-I: A-II and LpA-IV particles from plasma.

  1993cites this paper
• Preparation and characterization of spheroidal, reconstituted high-density lipoproteins with apolipoprotein A-I only or with apolipoprotein A-I and A-II.

  1993cites this paper
• Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-beta high-density lipoprotein particles.

  1993cites this paper
• Cholesterol esters selectively delivered in vivo by high-density-lipoprotein subclass LpA-I to rat liver are processed faster into bile acids than are LpA-I/A-II-derived cholesterol esters.

  1993cites this paper
• Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux.

  1993cites this paper
• Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance.

  1992cites this paper
• Mast cell-mediated inhibition of reverse cholesterol transport.

  1992cites this paper
• High density lipoproteins and reverse cholesterol transport

  1992cites this paper
• Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase.

  1992cites this paper
• Effect of the human cholesteryl ester transfer protein on the particle size redistribution of specific subpopulations of high density lipoproteins-3.

  1992cites this paper
• [Binding of apolipoproteins to HDL receptors sites. Role in the efflux of cholesterol].

  1991cites this paper
• Binding of apolipoproteins A to adipose cells: role of receptor sites in cholesterol efflux and purification of binding protein(s).

  1991cites this paper
• Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates.

  1990cites this paper